Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Athersys Inc (ATHX)

Athersys Inc (ATHX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 223,166
  • Shares Outstanding, K 149,776
  • Annual Sales, $ 24,290 K
  • Annual Income, $ -24,280 K
  • 60-Month Beta 0.32
  • Price/Sales 9.19
  • Price/Cash Flow N/A
  • Price/Book 6.35

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.41 +0.71%
on 07/19/19
1.86 -23.66%
on 06/20/19
-0.40 (-21.98%)
since 06/19/19
3-Month
1.39 +2.16%
on 04/22/19
2.03 -30.05%
on 05/16/19
+0.03 (+2.16%)
since 04/18/19
52-Week
1.35 +5.19%
on 04/18/19
2.23 -36.32%
on 09/26/18
-0.65 (-31.40%)
since 07/19/18

Most Recent Stories

More News
Athersys to Host Second Quarter Financial Results Call

Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, August 7, 2019, and will host a conference call shortly thereafter...

ATHX : 1.42 (-4.70%)
Global Translational Regenerative Medicines Market Outlook (2017-2026)

According to Stratistics MRC, the Global Translational Regenerative Medicines Market is growing at a CAGR of 13.9% from 2017 to 2026. Factors such as the increasing prevalence of degenerative diseases,...

ANIK : 40.62 (-1.12%)
BCLI : 3.99 (-1.72%)
NVS : 93.56 (-0.74%)
ATHX : 1.42 (-4.70%)
CELGZ : 0.47 (-5.98%)
Athersys to Present at Jefferies 2019 Healthcare Conference

Athersys, Inc. (NASDAQ: ATHX) announced today that Dr. Gil Van Bokkelen, Chairman and CEO, will present at the Jefferies 2019 Healthcare Conference taking place June 4-7, 2019 in New York City. Dr. Van...

ATHX : 1.42 (-4.70%)
Athersys to Participate in four Events at the International Society of Cell and Gene Therapy Conference

Athersys, Inc. (NASDAQ: ATHX) announced today its participation in several sessions at this year's International Society for Cell and Gene Therapy (ISCT) conference taking place May 29 - June 2, 2019 in...

ATHX : 1.42 (-4.70%)
Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference

Athersys, Inc. (Nasdaq: ATHX) announced additional favorable data from its exploratory Phase 1/2 acute respiratory distress syndrome (ARDS) clinical trial. Dr. Geoff Bellingan, Medical Director at University...

ATHX : 1.42 (-4.70%)
Athersys Announces Fast Track Designation From FDA for MultiStem(R) Program for Acute Respiratory Distress Syndrome

Athersys, Inc. (Nasdaq: ATHX) announced today that its clinical program evaluating MultiStem(R) cell therapy for the treatment of Acute Respiratory Distress Syndrome ("ARDS") has received Fast Track designation...

ATHX : 1.42 (-4.70%)
Athersys Reports First Quarter 2019 Results

Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended March 31, 2019.

ATHX : 1.42 (-4.70%)
Athersys, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / May 8, 2019 / Athersys, Inc. (NASDAQ: ) will be discussing their earnings results in their 2019 First Quarter Earnings to be held on May 8, 2019 at 4:30 PM Eastern Time.

ATHX : 1.42 (-4.70%)
Detailed Research: Economic Perspectives on Athersys, Crescent Point Energy, Snap-On, and Dover -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Athersys, Inc. (NASDAQ:ATHX), Crescent...

SNA : 150.00 (-0.88%)
DOV : 98.12 (+0.93%)
CPG : 3.12 (+4.00%)
ATHX : 1.42 (-4.70%)
Athersys (ATHX) Upgraded to Strong Buy: Here's What You Should Know

Athersys (ATHX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

ATHX : 1.42 (-4.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Soft. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ATHX with:

Business Summary

Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused primarily on treating critical care indications neurological conditions, cardiovascular diseases, inflammatory and...

See More

Key Turning Points

2nd Resistance Point 1.56
1st Resistance Point 1.49
Last Price 1.42
1st Support Level 1.38
2nd Support Level 1.34

See More

52-Week High 2.23
Fibonacci 61.8% 1.89
Fibonacci 50% 1.79
Fibonacci 38.2% 1.69
Last Price 1.42
52-Week Low 1.35

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar